Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or Remdesivir.

Autor: Bai, Francesca1 (AUTHOR) francesca.bai@asst-santipaolocarlo.it, Beringheli, Tomaso1 (AUTHOR), Vitaletti, Virginia1 (AUTHOR), Santoro, Andrea1 (AUTHOR), Molà, Francesco1 (AUTHOR), Copes, Alessandro1 (AUTHOR), Gemignani, Nicole1 (AUTHOR), Pettenuzzo, Sofia1 (AUTHOR), Castoldi, Roberto1 (AUTHOR), Varisco, Benedetta1 (AUTHOR), Nardo, Riccardo1 (AUTHOR), Lundgren, Lorenzo Brando1 (AUTHOR), Ligresti, Riccardo1 (AUTHOR), Sala, Matteo1 (AUTHOR), Albertini, Lorenzo1 (AUTHOR), Augello, Matteo1 (AUTHOR), Biasioli, Lorenzo1 (AUTHOR), Bono, Valeria1 (AUTHOR), Rovito, Roberta1 (AUTHOR), Bini, Teresa1 (AUTHOR)
Zdroj: Infectious Diseases & Therapy. Jul2024, Vol. 13 Issue 7, p1589-1605. 17p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje